The GLP1R agonist liraglutide inhibits hyperglucagonaemia induced by the SGLT2 inhibitor dapagliflozin

Bonner, C; Saponaro, C; Gmyr, V; Moerman, E; Thevent, J; Delalleau, N; Pasquetti, G; Quenon, A; Kerr-Conte, J; Pattou, F

DIABETOLOGIA, 2017; 60 ( ): S411